ABOS
Acumen Pharmaceuticals Inc
2.10$
-6.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -91.8% | +12.8% | +2.3% | +0.0% | -2.2% | +2.3% | – | – | – | +2.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.9% | -6.3% | +56.9% | +39.5% | +26.9% | -26.9% | +46.9% | -40.8% | -6.6% | -19.7% | +68.7% | – | |
| – | +6.9% | +2.5% | -9.0% | +3.5% | +0.2% | +1.5% | -9.4% | -1.7% | +2.8% | -0.2% | +1.8% | – | |
| – | +18.5% | -3.6% | +37.2% | +32.3% | +22.6% | -23.2% | +37.5% | -36.5% | -5.0% | -16.3% | +54.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +72.1% | +0.4% | +2.3% | +1.0% | -1.4% | +2.2% | +2.1% | +1.8% | -1.7% | +2.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -101.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.